R3VIVE.ME PT-141 20mg / 3ml contains Bremelanotide, a synthetic peptide studied for its interaction with melanocortin receptors and related signalling pathways.

Bremelanotide has been investigated in scientific research involving melanocortin receptor activity, cellular signalling, and physiological responses associated with the melanocortin system.

Laboratory investigations may examine:

Melanocortin receptor signalling
Peptide-receptor interactions
Cellular signalling pathways
Neuroendocrine research
Physiological response modelling
Peptide pharmacology studies

The 20mg / 3ml formulation provides a concentrated research preparation suitable for controlled laboratory investigation.

Key Features

R3VIVE.ME PT-141 formulation
20mg / 3ml preparation
Contains Bremelanotide
CAS: 189691-06-3
99% purity as stated on the packaging
Stabilised and pH balanced formulation
Suitable for controlled laboratory research

How to Use (Research Reference Only)

This product is intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Handling, storage, preparation, and experimental procedures should be determined according to the applicable laboratory protocol and institutional requirements.

Not intended for human consumption.

Research Applications

PT-141 / Bremelanotide is commonly investigated in research involving:

Melanocortin receptor activity
Peptide signalling
Neuroendocrine pathways
Receptor pharmacology
Cellular signalling research
Physiological pathway modelling

Research Disclaimer ( R3VIVE.ME PT-141 20mg)

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, or medical application.

What is PT-141?

PT-141, also known as Bremelanotide, is a synthetic peptide that has been studied for its activity at melanocortin receptors. Laboratory research examines its interaction with melanocortin signalling pathways and related physiological processes.